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Abstract
Background:  The introduction of new anti-malarial treatment that is effective, but more
expensive, raises questions about whether the high level of effectiveness observed in clinical trials
can be found in a context of family use. The objective of this study was to determine the factors
related to adherence, when using the amodiaquine/sulphadoxine-pyrimethamine (AQ/SP)
association, a transitory strategy before ACT implementation in Senegal.
Methods: The study was conducted in five rural dispensaries. Children, between two and 10 years
of age, who presented mild malaria were recruited at the time of the consultation and were
prescribed AQ/SP. The child's primary caretaker was questioned at home on D3 about treatment
compliance and factors that could have influenced his or her adherence to treatment. A logistic
regression model was used for the analyses.
Results: The study sample included 289 children. The adherence rate was 64.7%.   Two risks
factors for non-adherence were identified: the children's age (8–10 years) (ORa = 3.07 [1.49–6.29];
p = 0.004); and the profession of the head of household (retailer/employee versus farmer) (ORa =
2.71 [1.34–5.48]; p = 0.006). Previously seeking care (ORa = 0.28 [0.105–0.736], p=0.001]
satisfaction with received information (ORa =  0.45 [0.24–0.84]; p = 0.013), and the quality of
history taking (ORa =  0.38 [0.21–0.69]; p = 0.001) were significantly associated with good
compliance.
Conclusion: The results of the study show the importance of information and communication
between caregivers and health center staff. The experience gained from this therapeutic transition
emphasizes the importance of information given to the patients at the time of the consultation and
drug delivery in order to improve drug use and thus prevent the emergence of rapid drug
resistance.
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Background
Early treatment with effective anti-malarial drugs is the
main life-saving intervention for those at risk of malaria.
However, drug treatment is threatened by growing resist-
ance of Plasmodium falciparum to drugs that were once
effective against the parasite. Chloroquine resistance has
increased around the world, and this single drug treat-
ment has become useless in most malaria-endemic areas.
Resistance to sulphadoxine-pyrimethamine (SP) is also
widespread and its use must soon be discontinued. Resist-
ance to other anti-malarial drugs, such as amodiaquine,
varies, but their useful therapeutic life also appears lim-
ited. Consequently, nearly all African countries have seen
an unprecedented change in national drug policies in
recent years. In compliance with WHO recommenda-
tions, countries have discontinued chloroquine, as it
becomes ineffective, and now promote artemisin-based
combination therapy (ACT), as first-line treatment for
mild malaria.
Combining anti-malarial drugs with different modes of
action has been shown to improve the efficacy of individ-
ual drugs and has been proposed as a means of delaying
the spread of drug resistance and prolonging the life span
of anti-malarial drugs [1]. ACT has been shown to increase
cure rates [2]. However, for the successful deployment of
ACT, several issues need to be addressed [3], including
issues regarding patients' adherence, which has been
poorly documented so far. Measuring baseline levels of
adherence and identifying possible factors of non-adher-
ence are important steps before the introduction of this
new combination. Deciding on malaria drug policies
remains a major challenge in several countries. Not only
must the pharmacotherapeutic properties of the various
available treatment options be considered, but issues such
as end-users' ability to afford products, the level of finan-
cial support needed and expected practices in the use of
the drugs must also be taken into account.
The patient's treatment adherence is determined by
numerous factors, such as perceptions of the disease, per-
ceptions of treatment (taste, cost, complexity of the sched-
ule and side effects), patient factors, health staff factors
and the relationship between patient and nurses [4,5].
Efforts to improve the use of anti-malarial treatments by
providing the drugs through trained community health
workers [6], training shopkeepers and wholesalers [7] and
delivering prepackaged unit doses [8] or improved labe-
ling [9], have all been shown to enhance the percentage of
patients who receive and complete the recommended
dose. Many of these interventions, which had a positive
impact on treatment compliance, concern information
provided to the patient and communication between phy-
sician, pharmacist and patient or caregiver. It was hypoth-
esized that this plays an important role in increasing
caregiver compliance to anti-malarial treatment in Africa,
but its its impact relative to other factors is not currently
known. Faced with an average chloroquine treatment fail-
ure of 25% [10], Senegal changed its national malaria pol-
icy from chloroquine (CQ) to amodiaquine/
sulphadoxine-pyrimethamine (AQ/SP) in 2003. In 2006,
they shifted to ACT, the non co-formulated combination
amodiaquine/artesunate.
The introduction of this combination must be considered
as a test before ACT implementation; it is an opportunity
to assess health staff behaviour and public adherence to
new combinations. One year after introducing the new
treatment, a follow-up study was conducted to assess
patient adherence and the factors that might be related to
it.
Methods
Study area and population
The study was conducted in rural areas of the Thiès and
Mbour departments, 70 km east and southeast of Dakar,
respectively. The population, mainly of Sereer origin, lives
traditionally on one food crop (millet), one cash crop
(groundnuts) and livestock farming. To cope with the
agricultural crisis, new activities arose such as temporary
migration to urban centers, particularly the city of Mbour
and tourist areas. Malaria is endemic with seasonal out-
breaks. The annual rainy season is short (July–October),
with malaria transmission mainly restricted from August
to November. The average rainfall was 463 mm during the
1988–1996 period [11].
The study took place in 2004 during the rainy season. Five
health centers were chosen that are representative of
health care provision in rural Senegal (staff and technical
means, population scattering around the health centres,
recruitment area). Urban and touristic areas and health
centres with special NGO's health interventions were
avoided. A homogeneous geographic area representing 30
037 persons was defined. The selected health centres pro-
vided basic services to the study population: curative care,
immunization, prenatal care, delivery and malnutrition
management. The health structures are staffed by a nurse,
a community health worker and birth attendants. There
are no permanent physicians, midwives, laboratory facili-
ties or emergency transportation. They were chosen for
their sufficient patient attendance to ensure a daily mini-
mum recruitment of ill children. The average number of
patients attending per health center per day was 15 in
October and slightly lower in September and November.
Design and procedures
During the study period, all children between two and 10
years of age were identified by nurses during the consulta-
tion when they presented a presumptive mild malariaMalaria Journal 2009, 8:118 http://www.malariajournal.com/content/8/1/118
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attack. All children were prescribed a single dose of SP on
Day 0 (25 mg sulphadoxine/kg, 1.25 mg pyrimethamine/
kg) and one daily dose of AQ for three days (10 mg/kg/
day). A thick blood film was conducted to measure the
parasitaemia at D0 to have biological confirmation of the
diagnosis, but nurses did not know the results at the time
of prescription. Each provider was given a chart showing
the appropriate dosage by weight and age, defined by the
Senegalese National Malaria Control Programme. No
study team member was present at the health center. Each
evening, identification forms and blood smears were
received from the nurses. Children were included the day
after the last treatment dose (D3), when mothers/guardi-
ans were visited at home to explain the study design and
obtain their written consent. Apart from the study team,
no one was aware of this visit prior to our arrival.
Questionnaire
The questionnaire was addressed to caregivers and accom-
panying adults the day following end-of-treatment intake
(D3) or during the following three days in case of absence
(D4–D6). The individual questionnaire included nine
sections with questions related to: respondents' socio-eco-
nomic and demographic characteristics, history of febrile
illness, consultation at the health center, compliance,
child health status between D0 and the interview day,
adherence to treatment, knowledge about malaria, source
of information and attitudes towards health and drugs. If
the caregiver was different from the accompanying adult,
he/she was asked the latter questions from the section
concerning the health center and consultation. The last
section was addressed to children; they were asked about
the drugs (intake, taste) and about their disease and recov-
ery.
Interviews
A sample of 28 families was selected according to the
respective inclusion number in each health center. Struc-
tured interviews with caregivers took place in the home
the week following the health center consultation and
after the end of treatment. Structured interview guidelines
were developed focusing on nine themes: disease history,
consultation, new treatment, health center trust, locus of
control, opinion regarding correspondence between pre-
scription and what caregivers did, information on health
and disease, use of written prescription, compliance and
difficulties regarding drug intake.
Definition of adherence
Two levels of adherence were defined. Firstly, those who
took 80% of the prescribed dose of the two drugs were
considered "adherent." Secondly, strict full adherence
(SFA) for the prescribed dose described a patient who cor-
rectly followed the entire treatment including dose, dura-
tion and frequency. They were required to take the exact
dose prescribed every day for the three days for AQ and
the exact dose prescribed the first day for SP; a higher or a
lower dose taken on any one day resulted in the patients'
classification as "non-adherent."
Data analysis
Questionnaire data were entered in Dbase. Sample char-
acteristics and patient's classification were described as
percentages and presented with 95% confidence intervals
(CI). A logistic regression was used to identify factors
related to compliance. All independent variables were
tested individually (Chi2) and entered into the first model
since they were associated with compliance below a 0.30
level of significance. A backward step-by-step binary logis-
tic regression was used. Only statistically significant varia-
bles (p < 0.05) were kept in the final model. The STATA
program was used (STATA® 8.0, 2003; Stata Corporation,
College Station, Texas, USA).
Qualitative data were analysed using the thematic
method. Interviews were transcribed in their entirety.
From the transcribed conversations, patterns of experi-
ences could be listed. All data that related to previously
classified patterns were identified, and related patterns
were catalogued into sub-themes.
Results
Population
Among the 304 patients aged two to ten years considered
by the nurse to have mild malaria, 289 were included in
the study. The remaining 15 were prescribed quinine by
the nurse. One hundred and forty-four children had labo-
ratory confirmed malaria (parasitaemia > 2500/μl) and
145 were diagnosed presumptively by the nurse (117 were
negative and 28 had a parasitaemia < = 2500/μl). The
median age for all recruited children was 5.4 years. The sex
ratio (male/female) was 1:3. There were 14 caregivers
(5.9%) who did not buy all the prescribed drugs: 2 (0.7%)
did not buy AQ; 6 (2.1%) did not buy SP. The prescrip-
tion's mean cost was approximately 0.88 € [0.34–2.52].
The main caregiver was the mother (69.5%) followed by
the grand mother (13.2%) and the father (7.6%). For
17.3% of children, the accompanying adult at the health
center was different from the caregiver. The median age of
the caregiver was 36.7 years; 99.3% were Muslim. The pre-
dominant ethnic groups were: Sereer (60.5%), Wolof
(27.3%) and Peul (11.8%). Within the study group,
83.1% had received no formal education, while 13.8%
had been to primary school and 3.1% to secondary
school. Some 93.4% were not able to read the written pre-
scription.Malaria Journal 2009, 8:118 http://www.malariajournal.com/content/8/1/118
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Patient's compliance
First, patients were considered adherent if they took 80%
of the prescribed dose. Thus, 209 (72.3%) were adherent
to AQ and 245 (84.8%) to SP. Hence, a total of 187 chil-
dren (64.7%) were adherent to both drugs. Secondly,
39.4% of the children demonstrated strict full adherence
for AQ and 60.9% for SP. Overall, 37.7% of the children
strictly followed the prescription for the two drugs.
Health facilities description
Patients were recruited in five health facilities. The impact
of health facilities on treatment compliance was tested:
one of the health facilities had no nurse at the time of the
study and a community health worker was in charge of all
consultations. He was being trained by an NGO to treat
malaria with the new combinations within the framework
of a test to assess the new drugs' implementation at the
community level. It was noticed that compliance was bet-
ter at this health center: 17/19 (89.5%) children were
compliant, compared to 170/270 (62.3%) in the other
health facilities (p < 0.05). Concerning strict full adher-
ence, 68.4% of the caregivers administered treatment to
the child following strict guidelines in this health facility,
compared to 35.5% in other facilities (p < 0.05).
Predictors of adherence
In bivariate analyses, adherence was not associated with
biological confirmation of the disease (p = 0.434). Drug
factors such as taste (p = 0.7), galenic syrup/tablets (p =
0.45) and side-effects (p = 0.53) were not significantly
associated with adherence. Caregivers' factors, except
those linked to the information they received, were not
significantly associated with compliance: relationship to
the child (p = 0.60), formal education (p = 0.58), adult lit-
eracy (p = 0.56), activities (p = 0.73) and earnings (p =
0.77).
The health center factors were not significantly linked to
compliance: wait time (p = 0.47), health provider's status
(p = 0.54) – nurse/community health worker – with the
exception of the case of the particular health facility run
by a health worker.
80% adherence (see Additional file 1) was significantly (p
< 0.30) associated with information transmitted to car-
egivers about the discontinuation of chloroquine p =
0.28), the change in drugs (p = 0.12), the information
source (p = 0.09) and satisfaction with the information
received during consultation (p = 0.04). Only one factor
was linked to attitudes: not needing to continue treatment
if the child no longer appeared sick (p = 0.26). Two socio-
economic factors, head of household employment (p =
0.16) and children's age (p = 0.01), were related to adher-
ence. Factors related to history of febrile illness, the time
between the first symptom and consultation (p = 0.08)
and previously seeking health care from a traditional
healer or a community health center during this period (p
= 0.02), were also related to adherence. The attention the
patient received in terms of the health care provider's atti-
tude and discussion was linked to adherence (p = 0.002).
Strict full adherence was significantly associated with
almost the same factors (see Additional file 2), except
those related to children and caregiver, health status and
difficulties in administering the treatment.
Logistic regression models were fitted to examine the
influence of various predictive factors associated with
80% adherence and strict full adherence.
80% adherence regression model
All the variables above were included at the start of the
stepwise logistic regression. In the final model, two varia-
bles were risk factors for non-adherence: children eight to
10 years of age compared to young children from two to
four years of age (OR = 3.07; p = 0.004); and head of
household employment: retailer (OR = 2.71) or employee
(OR = 2.54) versus farmer (p = 0.006). Three variables
were protective factors for adherence: patients' perceived
satisfaction with received information (OR = 0.45; p =
0.013); previously seeking health care before the health
center consultation (OR = 0.278; p = 0.010) and correct
nurses' interviews about illness and children (i.e.: nurse
asked questions about history of febrile illness, symptoms
and previously seeking health care) (OR = 0.382; p =
0.001). Some variables were not selected in the final
model because they were not significant, but it was noted
that difficulties in administering treatment (p = 0.149)
and a long time-lapse between initial symptoms and con-
sultation (p = 0.057) tended to affect adherence; addition-
ally, improved adherence was observed when the health-
care provider was the first source of health information (p
= 0.171).
Strict full adherence
Two factors were significantly positively associated with
strict full adherence: satisfaction about the received infor-
mation (ORa = 0.546, p = 0.029) and another consulta-
tion before the consultation at the health center (ORa =
0.370; p = 0.009). Being not informed on reasons for dis-
continuing chloroquine tended to affect adherence (p =
0.125); correct nurses' interview (p = 0.083) and health-
care provider as first source of health information (p =
0.100) were also observed as tending to improve compli-
ance.
Consultation and drug sale observations
The results from these observations highlighted the short
duration of consultations, estimated between three and
five minutes. The nurse briefly examined the children: heMalaria Journal 2009, 8:118 http://www.malariajournal.com/content/8/1/118
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or she took temperature, weighed the child and some-
times did abdominal palpations and chest auscultation
when the child presented abdominal pain or coughing.
The nurse usually sat behind his or her desk and just spoke
to caregivers without performing an examination or aus-
cultation and only looked at the child's eyes to evaluate
anemia. Most of the time, he or she prescribed without
providing a diagnosis, and caregivers declared they were
not provided information about drugs. On the other
hand, most of the people were provided with information
by the drug supplier; however, they felt that they had not
been provided with enough information on drug intake.
The average time spent on each explanation was < 1
minute. The supplier cut the packages and provided expla-
nations while putting them in a bag. When patients were
interviewed at the health center exit, most of them could
not state the correct drug schedule and were mistaken
about drugs and dosages.
Caregivers' interview
Drug intake and accordance with the drug schedule
Almost all the caregivers said they followed up the drug
schedule in spite of describing very unorthodox drug
intake. Few mothers recognized they had made mistakes
and did not consider stopping treatment before its com-
pletion as a mistake. From the caregiver's perspective, the
goal is to cure the child's recovery, therefore, no longer
administering drugs to a child who appears cured does
not conflict with the drug schedule.
External locus of control
One mother told us: "God gives the disease, the husband pro-
vides money and nurses have to cure the children," expressing
an opinion held by the majority. Locus of control is exter-
nal when considering the disease and internal when con-
sidering the children's well being. Mothers explained their
role to us as maintaining hygiene for children, their
clothes and the home and providing good and healthy
food. Concerning diseases, they all believed their role was
to notice their child was ill, to ask the father or head of
household for money and to take the child to the health
center and then pray to God to cure their child. Mothers
said they played a passive role in their children's cure, lim-
ited to accompanying the child to the health center. Only
one of them told us about the leading role she played in
managing first the drugs and then the child's cure.
New treatment
At the beginning of the rainy season, all the families stated
they were not aware of the policy changes for malaria
treatment. Despite its yellow color, amodiaquine was
linked to chloroquine due to its bitterness and the shape
of the tablets; it was even called "yellow chloroquine." Fam-
ilies were unaware of the concept of association – the use
of two drugs to treat one disease. They did not associate SP
with malaria; the caregivers mistook it for an antipyretic
(aspirin or paracetamol) because of its similar characteris-
tics (white color and size). At the end of the rainy season,
people had heard about the new drug; they noticed chil-
dren did not spit out the drugs and one even said, "This
year malaria is less dangerous with the new drugs."
Use of written prescription
The written prescription is not used by the caregivers. They
just keep it "to prove they take care of their child." On the one
hand, 93.4% of the caregivers were unable to read it, on
the other hand, the nurses just wrote the prescription for
the drug provider. The only way to correctly administer
the treatment to the child is to memorize it: "You have to
memorize everything when the pharmacist explains it to you; if
you have any doubts, you will have to go back to the health
center for more explanations." Because of poor interpreta-
tion, the marks made on packages were a greater source of
misunderstanding than a way to improve compliance.
Discussion
This study aimed to analyse population adherence to new
strategies to treat malaria and to provide useful informa-
tion about factors related to compliance to these prescrip-
tions. Few studies are available on anti-malarial
combination adherence and too few of them broach fac-
tors that may have an impact on drug compliance. Most
of these studies were intervention studies and evaluated
the role of intervention – drug formulation and packaging
[8,12] and community education [6,9] – on patient drug
usage patterns. From these results, three groups of factors
were found to have an impact on compliance to anti-
malarial treatment.
Patient characteristics
In this study, the population was quite homogeneous,
preventing the use of socio-demographic factors that
might have an impact on compliance. In particular, for-
mal education and adult literacy were not associated with
compliance, but almost all of the caregivers did not
receive any formal education. In Zambia, children whose
caretakers had received some education had a lower risk
to be non-adherent [13]. In Uganda, Fogg also noticed
education may have an effect on the patients' understand-
ing of the instructions given in the clinic, the quality of the
patients' relationship with the health care provider and
the ability of the patient to interpret pictorial instructions
[14].
The association between being an employee or retailer
versus farmer and non-compliance seemed very surpris-
ing. It was hypothesized that a difference existed in exthe
household's social organization in cases of farmer fami-
lies. In this case, the caregiver is more frequently the
grandmother (p < 0.001) and older (p < 0.001); differentMalaria Journal 2009, 8:118 http://www.malariajournal.com/content/8/1/118
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generations are living in the same compound, and the
women share responsibilities. One may be responsible for
the specific task of drug administration and children's
health care. Conceivably, in this case, the woman has
more time and knew more about administering treatment
to children.
Compliance was better among young children (two to
four years) than the oldest (from eight to 10 years). The
oldest children were found to have more responsibilities
in the household. Immediately after feeling better, they
returned to their activities: going to school, farming and
herding cattle. They were spending most of their time
away from home, were under less parental or caregiver
supervision and were becoming more responsible for
their own care. They also had more freedom and could
refuse to take the drugs or spit them out behind their car-
egivers' back. Hence, it was necessary to interview them to
obtain complete information on drug intake. A few moth-
ers told the interviewers that they had to ask the children
directly about compliance. Children's own health beliefs
must be considered, and patient education for children
may be beneficial in improving treatment compliance
[15].
History and symptoms of febrile illness
In terms of the time-lapse between onset of symptoms
and the health center consultation, it was noticed that
those who had a previous consultation (traditional healer,
community health center or another health center) were
more compliant to treatment. Secondly, waiting for more
than two days to take children to the health center was a
risk factor of non-compliance.
This seems to be linked to the caregiver's anxiety; the more
reactive people who go to the health center at the onset of
symptoms or who have sought healthcare elsewhere were
more worried about their children's health and subse-
quently more compliant to treatment. In France, compar-
ison between emergency and non-emergency
consultations also revealed that family's anxiety was cor-
related with improved compliance [16].
Caregivers stated they would not give the tablets to a child
who no longer appeared sick. As one mother said, "When
your child is sick, all your thoughts are for him and you cannot
forget the drugs; but when he is feeling better, your mind is on
many other things, and it can happen that you forget." White
also noticed that people are less likely to take medicines
once they feel they have recovered from an illness [2]. The
same thing was observed in many compliance studies:
compliance was better when symptoms were more appar-
ent [17]. The same results were found for asthma; compli-
ance is better for symptomatic treatment than disease-
modifying drugs [18]. In developing countries, families
state they do not have enough money to take all sick peo-
ple to the health center; therefore keeping drugs to give to
other ill people appears more economical [19]. In Ecua-
dor, Yepez noticed among other factors that "getting cured
quickly" did not foster compliance. Non-compliance was
also associated with the drugs themselves: side effects and
reluctance to take drugs [20].
Information and relationships between patients and 
caregivers
Almost all the intervention studies reach a similar conclu-
sion: that appropriate information and well-designed
written material could have a positive impact on improv-
ing adherence and, with verbal consultation, are essential
for enabling patients to make appropriate decisions about
their medicine taking [6,9].
In this study, non-compliance seemed to be mainly linked
to lack of information. Unclear or incomplete explana-
tions were reported by 60% of the families interviewed as
a cause of poor compliance in a survey made among asth-
matic children [21,18]. Being satisfied with the received
information during consultation had a positive impact on
compliance. It was noticed that caregivers always received
poor information on drug intake, and this information
rarely corresponded to consultation guidelines. However,
people who were satisfied completed their treatment at
higher rates. This places emphasis on greater correspond-
ence between caregivers' expectations and the actual infor-
mation transmitted by health staff. Concerning the
impact of patient satisfaction on behaviour, Ley points
out: 'when a patient is not satisfied with the explanation or did
not understand it, his or her dissatisfaction will create a barrier
to treatment intake '[22]. Quality of care in terms of medi-
cal history taking and counseling was sub-optimal. The
quality of the nurses' interviews during consultation also
appears to be a factor in improving compliance. This
result refers to the overall quality of the relationship and
lies beyond the actual questioning [23]. The discussion
between nurse and patient plays an important role since
the nurse can use it to improve the diagnosis; it gives the
patient a feeling of being listened to as well. This analysis
has been clearly described by Morin, adding that the rela-
tionship between doctor and patient plays an important
role in the observed effects [5].
Conclusion
Although improved anti-malarial drug usage faces signifi-
cant logistical constraints, a number of simple, practical
interventions – both at the community and clinic level –
are effective: development of consultation guidelines,
health staff training, health education in schools, patient
counseling and illustrated instructions could be useful
tools. Nevertheless given the multiplicity of factors con-
tributing to poor adherence to medication, a multi-facto-Malaria Journal 2009, 8:118 http://www.malariajournal.com/content/8/1/118
Page 7 of 8
(page number not for citation purposes)
rial approach is required; it cannot be solved through a
single action. Improving compliance implies that patients
and health staffs understand both how and why drugs
should be taken correctly [24]: appropriate information is
essential for enabling patients to make appropriate deci-
sions about taking medicine.
Health officials will have to balance the need to make ACT
widely accessible with concerns about minimizing their
inappropriate use to give the few new alternatives availa-
ble for the treatment of malaria a chance to succeed and
to ensure treatment efficacy for the coming years by reduc-
ing therapeutic failures and subsequent chemoresistance.
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